Skip to content
Home/Companies/Healthcare/Prollenium
PR

Prollenium

Healthcare·Canada·Active·5yr hold

Prollenium is a consumer health company, headquartered in Canada.

Entry
2021
Hold
5yr
Status
Active
Est. EV
–

Who owns Prollenium?

Prollenium is currently owned by Peugeot Invest through Direct investment by Peugeot Invest (2025 vintage), since 2021. Across its history, Prollenium has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Peugeot Invest
Most recent investor
Peugeot Invest
Direct investment by Peugeot Invest · 2025 · Growth
2 ownership periods · full history below

Key facts

HQCanada
SectorConsumer Health

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by ARCHIMED and Peugeot Invest since 2021.
Co-invest · 2 holders · 2021 · present
ARCHIMED
ARCHIMEDActive
2021 · present · MED III · 2021 · Buyout
MOIC
–
Peugeot Invest
Peugeot InvestActive
2021 · present · Direct investment by Peugeot Invest · 2025 · Growth
MOIC
–

More from Direct investment by Peugeot Invest

Other portfolio companies in the same fund.

Solvares Group / Totalmobile
Active
SoftwareGermany· 2026
ArchiMed
Active
HealthcareUS· 2025
BroadStreet Partners
Active
FinancialsUS· 2025
JAB
Active
ConsumerLuxembourg· 2025
Novétude
Active
HealthcareFrance· 2025
Springbrook
Active
SoftwareUS· 2024

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
Active
Advent InternationalUS
Data refreshed weekly · Sourced from public filings